Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Vaporized Cannabis in Advanced COPD
NCT03060993Phase 2Unknown
- Sponsor
- McGill University
- Start
- Mar 2017
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabis in chronic obstructive pulmonary disease (COPD), sponsored by McGill University. Status: unknown.
02
Drugs
cannabis
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT03060993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03060993.